Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Vaccination didn't increase the risk of children or adolescents being diagnosed with pediatric MS within five years, a study ...

Tiziana's Phase 2 trial testing foralumab for nonactive secondary progressive multiple sclerosis (SPMS) has added six U.S.

Children with MS from poorer families or other disadvantaged circumstances tend to have more inflammation and brain damage, a ...

Higher levels of cholesterol in people with multiple sclerosis (MS) are associated with cognitive impairment, a study found.

MS patients undergoing hematopoietic stem cell transplant (HSCT) face physical and emotional challenges at each treatment ...

Hospitalization for severe COVID-19 more than doubles risk of MS, according to a study involving nearly 10 million people in ...

When faced with the obstacle course that is MS, columnist Ben Hofmeister remembers his strategy while in the Army Special Forces: Don't quit.

Columnist Susan Payrovi finds that it takes a force of nature — namely, the dark and cold of approaching winter — to fortify ...

Roche will acquire Poseida Therapeutics, building on a partnership for CAR T-cell therapies in development for MS and other diseases.

Nabiximols and other cannabis-based treatments were seen to work well at controlling spasticity, though responses vary among ...